When Your Muscle Tissue Runs Below Baseline: What the Młynarska Review Actually Says About Creatine and Metabolic Functi

When Muscle Maintenance Meets Metabolic Baseline

A new review from Młynarska et al. examines creatine monohydrate in combination with exercise — not as a performance hack, but through the lens of metabolic adequacy and muscle preservation. The authors focus on insulin resistance and sarcopenia (age-related muscle loss), both of which share a common denominator: skeletal muscle health. Their thesis: creatine may support glucose uptake pathways in muscle tissue, both insulin-dependent and insulin-independent, when paired with regular movement.

This is not a claim that creatine alone prevents Type 2 diabetes. It's a recognition that skeletal muscle is the body's largest glucose sink, and maintaining it adequately is part of the metabolic foundation. The review positions creatine as a support player in the adequacy lane — meeting baseline needs so the system doesn't start operating in the red. If your muscle tissue is chronically below optimal creatine saturation, you're asking it to manage glucose, contraction, and recovery on a partial tank.

We mention this because the Tortis Ritual (525mg daily) is calibrated to maintenance, not intervention. The research here examines supplementation at clinical doses combined with structured exercise protocols — a different use case. But the underlying principle aligns: muscle tissue that's adequately resourced is muscle tissue that can do its metabolic work. The goal isn't transformation. It's keeping the machinery running at baseline while you live your life.